Serial sampling captures early microbial development
Every-other-day stool sampling in 54 very low birth weight infants provides longitudinal observations spanning meconium and the first two weeks of life.
↳ Methods 2.1; Results
BACKGROUND: It is unknown to what extent the microbiome of preterm infants is influenced by hospital regimens including the use of different probiotics when it comes to the prevention of necrotizing enterocolitis (NEC).
METHODS: Prospective controlled multicenter cohort study including very low birth weight infants from three neonatal intensive care units (NICUs) between October 2015 and March 2017. During this time span, stool was sampled every other day during the first two weeks and samples were subjected to amplicon-based microbiome analyses. Out of these, seventeen negative controls were processed (German Registry of Clinical Trials (No.: DRKS00009290)).
RESULTS: The groups (3 × 18 infants) showed no statistically significant difference regarding gestational age, birth weight, APGAR scores and oxygen demand. 2029 different taxa were detected, including Enterococcus and Staphylococcus, as well as the probiotic genera Lactobacillus and Bifidobacterium predominating. The bacterial load was found to increase earlier on when probiotics were used. Without probiotics administration, Lactobacillus and Bifidobacterium contributed only marginally to the fecal microbiome. Some infants did not respond to probiotic administration. The samples from all centers participating reached a very similar diversity after two weeks while the microbiome samples from all three centers clustered significantly yet varied from each other.
CONCLUSION: Probiotics proved to be safe and initiated an earlier increase of bacterial load (with marked individual divergences), which might play a crucial role in the prevention of neonatal morbidities. Meconium was found not to be free of bacterial DNA, and oral antibiotics did not influence the fecal microbiome development negatively, and hospital regimes led to a center-specific, distinct cluster formation.
We found that hospital regimens significantly influenced the microbiome composition, diversity and quantity right from the beginning and all the way up to the more mature microbiome starting from two to three weeks of age onwards.
center, nutrition and regimen differences are inseparable in the three-center observational comparison
Probiotics were found to initiate an earlier increase of bacterial load, and this in turn might play a role in the prevention of neonatal morbidities.
confounded center comparisons cannot identify probiotic effects, and earlier load increase occurred only in Center G
The use of an oral antibiotic for prophylaxis of NEC was found to not be associated with a reduced diversity or reduced abundance of microbiome signatures (disproval of hypothesis 2).
concurrent feeding and drug-regimen differences prevent the center comparison from excluding adverse antibiotic effects
Probiotics proved to be safe
the small survivor-only cohort and absence of systematically analyzed safety endpoints cannot establish safety
Notably, certain infants from centers G (5/18) and K (5/18) did not show any response to probiotic treatment, with restricted colonization by Lactobacillus, as compared to the other infants in the same study group (“high responders”).
individual longitudinal profiles document restricted Lactobacillus abundance within both probiotic centers
Derived from the full evaluation — not a separate score.
Strengths
Every-other-day stool sampling in 54 very low birth weight infants provides longitudinal observations spanning meconium and the first two weeks of life.
↳ Methods 2.1; Results
The Results identify restricted Lactobacillus abundance in 5 of 18 infants in each probiotic center, documenting heterogeneity obscured by center averages.
↳ Results, individual probiotic-response paragraph
The Discussion considers primer bias in probiotic-genus abundance and possible environmental or formula-related sources of Geobacillus, connecting the observations to relevant literature.
↳ Discussion, primer-bias and Geobacillus paragraphs
Limitations
Probiotic, antibiotic, antifungal and feeding practices vary together across the three NICUs. The causal regimen conclusions and assertion of proven probiotic safety exceed what this comparison can establish.
↳ Methods 2.1; Abstract, Conclusion; Conclusions
The Abstract and Conclusions attribute earlier bacterial-load increase to probiotics, but Results identifies the earlier increase only in Center G. The Discussion explicitly states that probiotic-only Center K did not show faster increases.
↳ Abstract, Results and Conclusion; Results, qPCR paragraph; Discussion, quantitative PCR paragraph
Sample-wise comparisons use 383 observations from 54 infants without reported infant-level blocking or a repeated-measures model. Requiring three-week survival also restricts safety and NEC interpretations to survivors.
↳ Methods 2.1–2.2; Results, sample counts and diversity analyses
Serial stool sampling, 16S profiling and qPCR provide useful descriptive evidence of early microbiome development and individual variation across three NICUs. Because feeding and prophylaxis practices are nested within centers, the observed differences cannot establish separate probiotic or antibiotic effects. Sample-wise longitudinal testing and exclusion of early deaths further constrain inference. The general claim of probiotic-driven bacterial-load acceleration also conflicts with the Discussion's explicit account that the probiotic-only center showed no faster increase. Relevant literature discussion and a followable structure do not resolve these inferential and reporting limitations.
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
The study adds serial microbiome and bacterial-load observations in 54 very low birth weight infants across three NICUs, including individual variation in probiotic-genus abundance. Its advance remains descriptive because concurrent center practices cannot be separated.
Repeated sampling, qPCR and contamination filtering support descriptive measurements, but center-level confounding, sample-wise longitudinal inference and survivor selection substantially undermine regimen-specific conclusions. The general probiotic-load claim also conflicts with the center-specific account, as surfaced separately by the Red reliability flag.
The hypotheses-to-results structure is followable, but incomplete statistical reporting and inconsistent summaries impede precise interpretation. These reporting limitations support a score below the band for a consistently supported, clearly communicated argument.
The Discussion engages relevant work on microbial individuality, primer bias, Geobacillus and Klebsiella–NEC associations. Its limitations treatment does not adequately carry the combined center and feeding differences into the interpretation of regimen effects.
Lower confidence on Reporting — domain match limited.
Caveats4 of 4 checks
Ethics approval, parental consent, trial registration and an ENA accession are declared. The historical NEC incidence dataset is explicitly attributed separately from the prospective cohort.
Ethics approval: declared · Data availability: declared
36 of 37 checkable references verified
39 references in manuscript 2 are books, websites or datasets — counted, but not index-checkable
References not verified automatically are resolved manually within 24 hours.
No retraction or expression of concern found in Crossref (includes Retraction Watch).
Sources: Crossref (incl. Retraction Watch) ✓
The claim rests on one small prospective cohort of 54 infants with amplicon sequencing, without independent confirmation or linked clinical outcomes.
“Probiotics were found to initiate an earlier increase of bacterial load, and this in turn might play a role in the prevention of neonatal morbidities”
The paper links its probiotic findings to preventing neonatal morbidities but names no actor, profession or decision context.
Neonatologists and NICU teams could use these findings to refine NEC prophylaxis regimens and probiotic selection, shaping early gut colonisation to prevent neonatal morbidities.
Small single cohort, amplicon-based analyses, and no demonstrated link to NEC or other morbidities mean confirmatory trials are needed before regimens change.
Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3
AI-generated, human-governed. Something look off? Contact us to request a review.
Keep reading
Other papers Nabu has evaluated blind, starting with the same field.
Weiser-Fuchs, Maggauer, van Poppel, et al. · 2023 · Health sciences
Serum 3'SL concentrations significantly increased from fasting to 1 h after glucose load, while concentrations of the other HMOs were unaltered.
TentativeNeumann, Mahnert, Kumpitsch, et al. · 2023 · Clinical medicine
We demonstrate that preventive regimens have the highest impact on development and maturation of the gastrointestinal microbiome, enabling the establishment of a resilient microbial ecosystem that reduces pathogenic threats in at-risk preterm infants.
TentativeBandres-Meriz, Majali-Martinez, Hoch, et al. · 2021 · Clinical medicine
Pregnant women (week 4+0–11+6) with a high C-peptide concentration and low insulin sensitivity (ISHOMA) had decreased serum concentration of total n-3 PUFA
Supported